McGreevey, Vitale & NJ Reentry Corporation to Issue Report on the Opioid Crisis
McGreevey, Vitale & NJ Reentry Corporation to Issue Report on the Opioid Crisis
Recommendations Will Focus on ‘Clinical & Structural’ Treatment Challenges
TRENTON — Former Governor Jim McGreevey and Senator Joe Vitale, the chairman of the Senate Health Committee, will join with the New Jersey Reentry Corporation next Tuesday to release a report on the opioid crisis. The report, the “New Jersey Opioid Addiction Report: A Modern Plague,” will include recommendations on the “best practices to provide for a clinically-driven addiction treatment system that utilizes a continuum of care based on successful methods used elsewhere.”
- Governor Jim McGreevey, NJ Reentry Corporation.
- Senator Joe Vitale, Chairman, Senate Health, Human Services and Senior Citizens Committee.
- Dr. David R. Gastfriend, lead researcher on the American Society of Addiction Medicine’s (ASAM) Criteria for patient treatment matching. At Harvard Medical School and MGH over a 25-year span, he was Director of the MGH Addiction Research Program and founded the MGH/McLean Hospital Addiction Psychiatry Fellowship.
- Dr. Thomas McLellan, Scientific Board, Shatterproof, a national non-profit addiction research foundation, statement of support.
- Dr. Douglas B. Marlowe, National Association of Drug Court Professionals (NADCP), statement of support.
- Dr. Aakash Shah, Medical Director NJRC, MD Harvard University Medical School, MBA Oxford University.
- What: NJRC’s New Jersey Opioid Addiction Report: A Modern Plague Release.
- Where: New Jersey State House, Room 103, 125 W. State Street, Trenton
- When: Tuesday, September 25 at 11:00 a.m.
The New Jersey Reentry Corporation is committed to providing critically needed services to court involved individuals to empower them to achieve healthy self-sufficiency, thereby reducing recidivism and fostering safer communities.
